IMMP
IMMUTEP Ltd
$0.3689
-0.30%
$54.3M
No data for this timeframe.
Vol
Market Cap$54.3M
Cap SizeMicro Cap
Analyst ConsensusBuy (50%)
Inst. Holders3 funds
Inst. Value$312.8K
Inst. Activity1 buys / 1 sells
Reddit Sentiment50° Neutral
Recent Activity
Inst.
TWO SIGMA INVESTMENTS, LP — NEW
94,595 shares ($270.5K)
Inst.
MORGAN STANLEY — NEAR_EXIT
6,572 shares ($18.8K)
Jun 4, 2026
other
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
<p align="justify"><b><b>SYDNEY, AUSTRALIA, June 04, 2026 (GLOBE NEWSWIRE) -- </b></b><a href="htt
Analyst Ratings
1Strong Buy
3Buy
4Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 13, 2026 | Citizens | DOWNGRADE | Market Outperform → Market Perform |
| Mar 13, 2026 | Baird | DOWNGRADE | Outperform → Neutral |
| Feb 23, 2026 | Citizens | INITIATE | Market Outperform |
| Feb 17, 2026 | Citizens | INITIATE | Market Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-0.25 ▲ +4.5% | $-0.25 — $-0.25 | 9% YoY | 1 |
| Next FY | $-0.22 ▲ +10.2% | $-0.22 — $-0.22 | 12% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| TWO SIGMA INVESTMENTS, LP | $270.5K | NEW |
| BANK OF AMERICA CORP | $23.4K | DOUBLED |
| MORGAN STANLEY | $18.8K | NEAR_EXIT |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
3 institutional holders with $312.8K total value (109,361 shares) as of 2025-Q4. Top holders: TWO, BANK, MORGAN.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | 94,595 | $270.5K | 86.5% | NEW |
| 2 | BANK OF AMERICA CORP /DE/ | 8,194 | $23.4K | 7.5% | DOUBLED +300.3% |
| 3 | MORGAN STANLEY | 6,572 | $18.8K | 6.0% | NEAR_EXIT -96.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | NEW | — | 94,595 | — | $270.5K | 2025-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 165,966 | 6,572 | -96.0% | $18.8K | 2025-Q4 |
| MORGAN STANLEY | ADD | 119,466 | 165,966 | +38.9% | $290.4K | 2025-Q3 |
| UBS Group AG | TRIM | 64,842 | 25,094 | -61.3% | $43.9K | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 14,276 | 119,466 | +736.8% | $195.9K | 2025-Q2 |
| UBS Group AG | DOUBLED | 24,008 | 64,842 | +170.1% | $106.3K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 2,220 | 8,887 | +300.3% | $14.6K | 2025-Q2 |
| CITADEL ADVISORS LLC | DOUBLED | 30,954 | 62,838 | +103.0% | $110.6K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 29,589 | 14,276 | -51.8% | $25.1K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 50,982 | 30,954 | -39.3% | $67.2K | 2024-Q4 |
| MORGAN STANLEY | ADD | 15,077 | 29,589 | +96.3% | $64.2K | 2024-Q4 |
| UBS Group AG | DOUBLED | 1,849 | 23,019 | +1144.9% | $50.0K | 2024-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 105,301 | 15,077 | -85.7% | $33.3K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (50% buy). Based on 8 analysts: 1 strong buy, 3 buy, 4 hold, 0 sell, 0 strong sell.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$-0.25 | $-0.25 | $-0.25 | 9.2% | +4.5% | 1↑ 0↓ | $0.0B | 87.4% | 1 |
| Next FY 2027-06-30 |
$-0.22 | $-0.22 | $-0.22 | 12.0% | +10.2% | 1↑ 0↓ | $0.0B | -86.4% | 1 |
2 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 13, 2026 | Citizens | DOWNGRADE | Market Outperform | Market Perform |
| Mar 13, 2026 | Baird | DOWNGRADE | Outperform | Neutral |
| Feb 23, 2026 | Citizens | INITIATE | — | Market Outperform |
| Feb 17, 2026 | Citizens | INITIATE | — | Market Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 3 | 4 | 0 | 0 | 50% | |
| May 1, 2026 | 1 | 3 | 4 | 0 | 0 | 50% | |
| Apr 1, 2026 | 1 | 3 | 4 | 0 | 0 | 50% | |
| Mar 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Feb 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Jan 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
4 mentions
2 bullish
2 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 17, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 17, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 16, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 15, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
IMMP is Undervalued
▲ 1
💬 1
⚡ 0.5
Jun 4, 2026
other
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
<p align="justify"><b><b>SYDNEY, AUSTRALIA, June 04, 2026 (GLOBE NEWSWIRE) -- </b></b><a href="https://www.globenewswire.com/Tracker?data=jknfmU9lVh
Jun 2, 2026
short_volume
Short Volume: IMMP — 83.7% short (0.8M / 0.9M)
Short: 766,529 | Exempt: 89,480 | TRF Vol: 915,300 | Short Ratio: 83.7% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: IMMP — 58.0% short (0.6M / 1.0M)
Short: 575,435 | Exempt: 17,573 | TRF Vol: 991,586 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: IMMP — 55.3% short (0.8M / 1.4M)
Short: 781,218 | Exempt: 0 | TRF Vol: 1,412,789 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: IMMP — 56.1% short (0.4M / 0.8M)
Short: 433,478 | Exempt: 5,923 | TRF Vol: 772,740 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
short_interest
FTD: IMMP — 1,228,906 shares ($0.7M) failed to deliver
Settlement: 20260422, Price: $0.59, FTD Value: $725,054.54, IMMUTEP LTD SPONSORED ADR (AUS
Apr 21, 2026
short_interest
FTD: IMMP — 2,703,643 shares ($1.7M) failed to deliver
Settlement: 20260421, Price: $0.62, FTD Value: $1,676,258.66, IMMUTEP LTD SPONSORED ADR (AUS
Apr 20, 2026
short_interest
FTD: IMMP — 4,529,684 shares ($2.6M) failed to deliver
Settlement: 20260420, Price: $0.58, FTD Value: $2,627,216.72, IMMUTEP LTD SPONSORED ADR (AUS
Apr 17, 2026
short_volume
Short Volume: IMMP — 58.5% short (3.6M / 6.2M)
Short: 3,610,395 | Exempt: 200,401 | TRF Vol: 6,168,163 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
Apr 17, 2026
short_interest
FTD: IMMP — 8,520,034 shares ($4.9M) failed to deliver
Settlement: 20260417, Price: $0.58, FTD Value: $4,941,619.72, IMMUTEP LTD SPONSORED ADR (AUS
Apr 16, 2026
short_volume
Short Volume: IMMP — 56.2% short (15.0M / 26.7M)
Short: 15,002,868 | Exempt: 170,981 | TRF Vol: 26,717,932 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
Apr 16, 2026
short_interest
FTD: IMMP — 12,480,918 shares ($6.7M) failed to deliver
Settlement: 20260416, Price: $0.54, FTD Value: $6,739,695.72, IMMUTEP LTD SPONSORED ADR (AUS
Apr 15, 2026
other
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
<p align="justify"><b><b>SYDNEY, AUSTRALIA, April 15, 2026 (GLOBE NEWSWIRE) -- </b></b><a href="https://www.globenewswire.com/Tracker?data=GSK04NR_M
Mar 17, 2026
short_interest
FTD: IMMP — 1,920,035 shares ($0.9M) failed to deliver
Settlement: 20260317, Price: $0.47, FTD Value: $902,416.45, IMMUTEP LTD SPONSORED ADR (AUS
Mar 16, 2026
short_interest
FTD: IMMP — 2,883,506 shares ($1.4M) failed to deliver
Settlement: 20260316, Price: $0.48, FTD Value: $1,384,082.88, IMMUTEP LTD SPONSORED ADR (AUS